share_log

东诚药业(002675.SZ):合肥核药生产中心投入运营

Yantai Dongcheng Biochemicals (002675.SZ): The operation of Hefei nuclear medicine production center has been put into operation.

Zhitong Finance ·  Jun 13 19:05

Yantai Dongcheng Biochemicals (002675.SZ) announced that the company has received a notification from its wholly-owned subsidiary, Nanjing Jiangyuan Andico Electronic Research and Development...,

According to an announcement by Easton Pharmaceuticals (002675.SZ), the company has received a notification from its wholly-owned subsidiary, Nanjing Jiangyuan Andico Electronic Research and Development Co., Ltd. (referred to as 'Andico') informing it that it has received a 'Radioactive Drug Production License' issued by the Jiangsu Provincial Drug Administration, establishing a new Hefei Nuclear Medicine Production Center in Anhui. The approval of this review signifies that Andico's Hefei Nuclear Medicine Production Center has met production requirements and Andico will add a new nuclear medicine production center.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment